Immunomodulators for Skin Cancer

September 2004 | Volume 3 | Issue 5 | Original Article | 533 | Copyright © September 2004

Adriana M Villa and MD, Brian Berman MD PhD

Abstract
Therapeutic interventions to augment tumor antigenicity or increase the host’s immune response against cancer cells include recombinant cytokines, immune modulators, vaccination with tumor antigens, T cell-based immunotherapy, and gene therapy. We describe the current role of the immunomodulators (up-regulators of the immune response) in the therapy of skin cancer (non melanoma skin cancer, melanoma, lymphoma, Kaposi sarcoma, and extramammary Paget’s disease).